Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early identification of frailty: Developing an international delphi consensus on pre-frailty.
Sezgin D, O'Donovan M, Woo J, Bandeen-Roche K, Liotta G, Fairhall N, Rodríguez-Laso A, Apóstolo J, Clarnette R, Holland C, Roller-Wirnsberger R, Illario M, Mañas LR, Vollenbroek-Hutten M, Doğu BB, Balci C, Pernas FO, Paul C, Ahern E, Romero-Ortuno R, Molloy W, Cooney MT, O'Shea D, Cooke J, Lang D, Hendry A, Kennelly S, Rockwood K, Clegg A, Liew A, O'Caoimh R. Sezgin D, et al. Among authors: pernas fo. Arch Gerontol Geriatr. 2022 Mar-Apr;99:104586. doi: 10.1016/j.archger.2021.104586. Epub 2021 Nov 20. Arch Gerontol Geriatr. 2022. PMID: 34896797
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects.
Iavarone A, Carpinelli Mazzi M, Russo G, D'Anna F, Peluso S, Mazzeo P, De Luca V, De Michele G, Iaccarino G, Abete P, Milan G, Garofalo E, Musella C, O'Caoimh R, Molloy W, De Joanna G, Manzo V, Ambra FI, Postiglione A, Illario M; Working Group. Iavarone A, et al. Aging Clin Exp Res. 2019 Mar;31(3):353-360. doi: 10.1007/s40520-018-0981-2. Epub 2018 Jun 8. Aging Clin Exp Res. 2019. PMID: 29949025
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Among authors: pernas f. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ. Franzmann EJ, et al. Among authors: pernas fg. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55. doi: 10.1158/1055-9965.EPI-06-0011. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17627000
12 results